Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
Crossref DOI link: https://doi.org/10.1186/s13045-015-0213-6
Published Online: 2015-10-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Köhnke, Thomas
Krupka, Christina
Tischer, Johanna
Knösel, Thomas
Subklewe, Marion